Industry provides endless methods in crafting solutions for patients.
Marina Acosta Enslen
Advertisement
Director, Clinical Management, Rho
Articles by Marina Acosta Enslen
COVID-19 pandemic forces compliancy within organizations following FDA’s 2018 revision of Good Clinical Practice in federal registry.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
2
Data Quality Across the Clinical Trial Lifecycle: What It Takes to Fully Trust Your Data
3
ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps
4
The CRA of the Future: From Monitoring Activity to Strategic Site Partnership
5